Clinical trials: Breastcancer
Breast Cancer
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
This post-approval study is designed to determine the performance of the FDA-approved GeneSearch™ BLN Assay when compared to the site's standard of care permanent section histological evaluation, and when compared to more…
- Trial name
- NCT00595296
- Testing
- GeneSearch™ Breast Lymph Node (BLN) Assay
- Where
- 6 sites in United States
- Volunteers
- 461 people
- Sponsor
- Janssen Diagnostics, LLC
Breastcancer
A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients
This is a multicenter, open-label, single-arm PK study in patients for whom paclitaxel treatment is indicated.
- Trial name
- NCT03165955
- Testing
- Oraxol
- Where
- 6 sites in Taiwan
- Volunteers
- 28 people
- Sponsor
- Health Hope Pharma
Breastcancer, Breast Neoplasm
SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
This is a single arm, open label study of SV-BR-1-GM, a targeted immunotherapy for breast cancer. Eligible patients will have histological confirmation of breast cancer with recurrent and/or metastatic lesions.
- Trial name
- NCT03066947
- Testing
- SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b
- Where
- 5 sites in United States
- Volunteers
- 24 people
- Sponsor
- BriaCell Therapeutics Corporation
Breastcancer
An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007
KX-ORAX-008 is an extension study of patients who completed KX-ORAX-007 without disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 and who wish to continue Oraxol treatment.
- Trial name
- NCT04168957
- Testing
- Oraxol
- Where
- 5 sites in Taiwan
- Volunteers
- 11 people
- Sponsor
- Athenex, Inc.
Breastcancer
A PK Study of Oraxol in Breast Cancer Patients
This is a multicenter, open-label, single-arm PK study in approximately 24 breast cancer patients for whom paclitaxel treatment is indicated.
- Trial name
- NCT04993040
- Testing
- Oraxol
- Where
- China
- Volunteers
- 24 people
- Sponsor
- Athenex, Inc.
Relapsed Breast Cancer, Neoplasms, Breast
Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
This study will evaluate the safety and efficacy of lapatinib in combination with chemotherapy (capecitabine, docetaxel, nab-paclitaxel) in subjects with ErbB2-overexpressing breast cancer whose disease has progressed during or…
- Trial name
- NCT00479856
- Testing
- Lapatinib, Capecitabine, Docetaxel
- Where
- 28 sites in United States
- Volunteers
- 9 people
- Sponsor
- GlaxoSmithKline
Breastcancer
Immunotherapy Vaccine and Herceptin in Breast Cancer
The purpose of this trial is to determine if combination immunotherapy with HER2/neu GP2 peptide + GM-CSF vaccine and trastuzumab is safe and immunologically effective in treatment of patients with HER2/neu over-expressing breast…
- Trial name
- NCT03014076
- Testing
- GP2 peptide + GM-CSF vaccine plus trastuzumab, Trastuzumab
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Cancer Insight, LLC